Tuesday, 16 Jul 2019

You are here

RheumNow Podcast - Scurvy and Mechanics (2-1-19)

Dr. Jack Cush reviews new journal articles, news reports, and more from the past week on RheumNow.com.

  1. MMWR reports SCURVY outbreak in the Sudanese; NOTE this also occurs where you live, especially in young people with Horrible, monotonous diets. Sxs include arthralgias, lethargy, fatigue, gingival pain/bleeding, hyperkeratotic skin changes, chest pain https://t.co/v41LdnheOu   
  2. 17.2% of 576 autoimmune pts had Mechanic hands: 50% MCTD; 35% DM; 15% PSS; 15% of UCTD; 14% Sjogren’s; NO SLE pts. 81% Mechanic+ had abnl capillaroscopy. DM w/ Mechanics had more Raynauds, Jo-1+ & abnl capillaroscopy https://t.co/igdTHUYmSj
  3. UK pts w/ hemochromatosis homozygous for HFE p.C282Y finds men 40-70 w/ incr risk of Hemochr Dx, (OR 411), liver Dz (4.3), RA (2.23), OA (2.01) & DM (1.53). Heterozygotes w/ hemochromatosis was more common but morbidity was modest. https://t.co/8NyRRJGqTl
  4. Comparison of 187 RA and 157 without inflammatory joint dz, shows a significant association between periodontitis and RA (adjusted OR = 20.57). Periodontitis severity was significantly associated with RA disease activity (p < 0.001) https://t.co/Bmv2LKRnYz
  5. 2014-2015 study of 750K from Southern Sweden shows 24% of OA patients used opioids (2 fold higher than those without knee or hip OA).
  6. 101 kids w/ Takayasus finds 3% mortality in Yr 1, 50% morbidity in 5 yrs. Median onset was 14 yrs, 76%F. Sxs include HTN (70%), BP discrep(55%), bruits (52%), pulse deficits (38%). Artery Inv: Renal (62%), aorta (43%), subclavian (44%), carotid (43%). https://t.co/nXdjLviRyk
  7. No Difference in Oral or IV Antibiotics for Bone & Joint Infections     
  8. Low IBD Risk with Secukinumab   
  9. Vertebroplasty and Kyphoplasty Shown to Be Ineffective 
  10. Update on Pregnancy Management in RA  

 

Add new comment

More Like This

RheumNow Podcast – Boiling Hot MAS (7.12.19)

Dr. Jack Cush reviews this week's news and journal reports featured on RheumNow.com. PsA v. non-PsA pregnancies, Still's disease, lupus, nutritional supplements and dietary interventions, use of cannabis, tanezumab in OA, CBD oils and more.

Be ‘on point’: Guidelines for rheumatic complications of immunotherapy

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. At EULAR 2019, Madrid, several recommendations including RA, SLE, and Sjogren’s syndrome have been developed. Agreement for principles with respect to the treatment of immune mediated adverse events from cancer immunotherapy are lacking.

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019, including low-dose steroids in hand OA, ABA vs. ADA in double positive RA patients, psoriasis predictors of PsA, tildrakizumab and more.

EULAR 2019 – Day 3 Report

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.

Ultrasound Reveals Which Anti-CCP Positive Patients Progress to Arthritis 

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Power Doppler signal on baseline ultrasound exam may well help stratify anti-CCP positive patients with musculoskeletal symptoms but no clinical synovitis, according to data from the Leeds Institute of Rheumatic and Musculoskeletal Medicine presented at EULAR 2019.